Back to RHEL.CN

Rhelion Life Sciences Corp.

RHEL.CN • Financial Statements

Showing annual data (3 years)

Rhelion Life Sciences Corp. annual financial summary

From company filings. Fiscal years, latest first.

MetricFY2025FY2024FY2023
Revenue$4.9M$4.8M$3.9M
Net income$-4.0M$-7.6M$-5.4M
Operating cash flow$-1.5M$-3.2M$-4.4M
Free cash flow$-2.0M$-3.9M$-6.5M
Cash & short-term investments$12.3M$14.2M$18.5M
Total debt$2.2M$1.7M$1.8M

Revenue

Revenue

Profitability (Gross Profit, EBITDA, Net Income)

Profitability (Gross Profit, EBITDA, Net Income)

Margins (Gross, EBITDA, Net)

Margins (Gross, EBITDA, Net)

Showing the last 3 fiscal years. Full history, including 43 quarters, is free with an account.

Want the Complete Picture?

Valuation, risk assessment, competitive positioning, and key insights — all in one report.

Free account:3 reports remaining